Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07628192 · ClinicalTrials.gov registry record · NA

Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial

A NA study, sponsored by The Cleveland Clinic.

Not yet
Registry status
NA
Development phase
118
Enrollment target

NCT07628192 is a NA study that has not yet begun recruiting, run by The Cleveland Clinic. The registered enrollment target is 118 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07628192, a NA study, has not yet begun recruiting, sponsored by The Cleveland Clinic.

NOT YET RECRUITING
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

This study outlines a randomized controlled trial evaluating two brief suicide-specific interventions for adolescents aged 12-17 who are hospitalized for suicidal ideation or attempts. Suicide remains a leading cause of death among youth, and many adolescents are discharged from inpatient care without targeted, suicide-focused treatment, contributing to high rates of readmission and ongoing risk. This study seeks to address that gap by comparing the effectiveness of the Collaborative Assessment and Management of Suicidality-Brief Intervention (CAMS-BI) with the Stanley-Brown Safety Planning Intervention (SPI), both delivered as single-session interventions during inpatient hospitalization. Participants (N=118) will be randomly assigned to receive either CAMS-BI or SPI. CAMS-BI is a therapeutic, collaborative framework that focuses on identifying and addressing the underlying psychological drivers of suicidality, while SPI is a structured, practical approach that emphasizes immediate safety through coping strategies, support systems, and means restriction. Following the intervention, participants will be monitored for 90 days post-discharge, with follow-ups at 30, 60, and 90 days. The primary outcome is the rate of psychiatric readmissions and suicide-related emergency department visits within 90 days of discharge. Secondary outcomes include changes in suicidal ideation, measured by the Beck Scale for Suicide Ideation, and caregiver confidence in managing their child's safety. Additional measures include distress levels, hopelessness, treatment satisfaction, and engagement. The study hypothesizes that CAMS-BI will result in lower readmission rates, greater reductions in suicidal ideation, and improved caregiver confidence compared to SPI. Both interventions produce individualized safety or stabilization plans that are shared with patients and caregivers and incorporated into discharge planning to support continuity of care. Safety protocols are emphasized through

Interventions

  • BEHAVIORAL CAMS Brief Intervention
  • BEHAVIORAL Stanley-Brown Safety Planning Intervention

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2026-08-01
Est. Completion 2027-03-01
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT07628192

The ClinicalTrials.gov registry entry for NCT07628192 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which CAMS Brief Intervention is the first listed.

NCT07628192 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07628192 about?

NCT07628192 is a clinical study titled "Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial". This study outlines a randomized controlled trial evaluating two brief suicide-specific interventions for adolescents aged 12-17 who are hospitalized for suicidal ideation or attempts. Suicide remains a leading cause of death among youth, and many adolescents are discharged from inpatient care witho...

What is the current status of trial NCT07628192?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2026-08-01. Estimated completion is 2027-03-01.

What interventions are being tested in trial NCT07628192?

The interventions under investigation include: CAMS Brief Intervention (BEHAVIORAL), Stanley-Brown Safety Planning Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07628192?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.